189 related articles for article (PubMed ID: 35008720)
1. Benefits of Usage of Immobilized Silver Nanoparticles as
Korzekwa K; Kędziora A; Stańczykiewicz B; Bugla-Płoskońska G; Wojnicz D
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008720
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial and antibiofilm potential of silver nanoparticles against antibiotic-sensitive and multidrug-resistant Pseudomonas aeruginosa strains.
de Lacerda Coriolano D; de Souza JB; Bueno EV; Medeiros SMFRDS; Cavalcanti IDL; Cavalcanti IMF
Braz J Microbiol; 2021 Mar; 52(1):267-278. PubMed ID: 33231865
[TBL] [Abstract][Full Text] [Related]
3. 3,6-Di(pyridin-2-yl)-1,2,4,5-tetrazine (pytz)-capped silver nanoparticles (TzAgNPs) inhibit biofilm formation of Pseudomonas aeruginosa: a potential approach toward breaking the wall of biofilm through reactive oxygen species (ROS) generation.
Chakraborty P; Joardar S; Ray S; Biswas P; Maiti D; Tribedi P
Folia Microbiol (Praha); 2018 Nov; 63(6):763-772. PubMed ID: 29855854
[TBL] [Abstract][Full Text] [Related]
4. Effect of nano-silver, nano-copper, deconex and benzalkonium chloride on biofilm formation and expression of transcription regulatory quorum sensing gene (rh1R) in drug-resistance Pseudomonas aeruginosa burn isolates.
Gholamrezazadeh M; Shakibaie MR; Monirzadeh F; Masoumi S; Hashemizadeh Z
Burns; 2018 May; 44(3):700-708. PubMed ID: 29290510
[TBL] [Abstract][Full Text] [Related]
5. Antibiofilm properties of chemically synthesized silver nanoparticles found against Pseudomonas aeruginosa.
Palanisamy NK; Ferina N; Amirulhusni AN; Mohd-Zain Z; Hussaini J; Ping LJ; Durairaj R
J Nanobiotechnology; 2014 Jan; 12():2. PubMed ID: 24422704
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of silver nanoparticles and polymyxin B against biofilm produced by
Salman M; Rizwana R; Khan H; Munir I; Hamayun M; Iqbal A; Rehman A; Amin K; Ahmed G; Khan M; Khan A; Amin FU
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2465-2472. PubMed ID: 31187657
[No Abstract] [Full Text] [Related]
7. In Vivo and in Vitro activity of colistin-conjugated bimetallic silver-copper oxide nanoparticles against Pandrug-resistant Pseudomonas aeruginosa.
Abdul Hak A; Zedan HH; El-Mahallawy HA; El-Sayyad GS; Zafer MM
BMC Microbiol; 2024 Jun; 24(1):213. PubMed ID: 38886632
[TBL] [Abstract][Full Text] [Related]
8. Effect of glutathione-stabilized silver nanoparticles on expression of las I and las R of the genes in Pseudomonas aeruginosa strains.
Pourmbarak Mahnaie M; Mahmoudi H
Eur J Med Res; 2020 May; 25(1):17. PubMed ID: 32434568
[TBL] [Abstract][Full Text] [Related]
9. Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis.
Kalishwaralal K; BarathManiKanth S; Pandian SR; Deepak V; Gurunathan S
Colloids Surf B Biointerfaces; 2010 Sep; 79(2):340-4. PubMed ID: 20493674
[TBL] [Abstract][Full Text] [Related]
10. Silver nanoparticles as a bioadjuvant of antibiotics against biofilm-mediated infections with methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in chronic rhinosinusitis patients.
Feizi S; Cooksley CM; Nepal R; Psaltis AJ; Wormald PJ; Vreugde S
Pathology; 2022 Jun; 54(4):453-459. PubMed ID: 34844745
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo antimicrobial activity of combined therapy of silver nanoparticles and visible blue light against Pseudomonas aeruginosa.
Nour El Din S; El-Tayeb TA; Abou-Aisha K; El-Azizi M
Int J Nanomedicine; 2016; 11():1749-58. PubMed ID: 27175075
[TBL] [Abstract][Full Text] [Related]
12. Fucoidan-Stabilized Gold Nanoparticle-Mediated Biofilm Inhibition, Attenuation of Virulence and Motility Properties in
Khan F; Manivasagan P; Lee JW; Pham DTN; Oh J; Kim YM
Mar Drugs; 2019 Apr; 17(4):. PubMed ID: 30987163
[TBL] [Abstract][Full Text] [Related]
13. Fabrication of inhaled hybrid silver/ciprofloxacin nanoparticles with synergetic effect against Pseudomonas aeruginosa.
Al-Obaidi H; Kalgudi R; Zariwala MG
Eur J Pharm Biopharm; 2018 Jul; 128():27-35. PubMed ID: 29654885
[TBL] [Abstract][Full Text] [Related]
14. Facile green synthesis of baicalein fabricated gold nanoparticles and their antibiofilm activity against Pseudomonas aeruginosa PAO1.
Rajkumari J; Busi S; Vasu AC; Reddy P
Microb Pathog; 2017 Jun; 107():261-269. PubMed ID: 28377235
[TBL] [Abstract][Full Text] [Related]
15. Does Conjugation of Silver Nanoparticles with Thiosemicarbazide Increase Their Antibacterial Properties?
Honarmand T; Sharif AP; Salehzadeh A; Jalali A; Nikokar I
Microb Drug Resist; 2022 Mar; 28(3):293-305. PubMed ID: 35005985
[TBL] [Abstract][Full Text] [Related]
16. Biosynthesis of Silver Nanoparticles from
Shakhatreh MAK; Al-Rawi OF; Swedan SF; Alzoubi KH; Khabour OF; Al-Fandi M
Curr Pharm Biotechnol; 2021; 22(9):1254-1263. PubMed ID: 33081683
[TBL] [Abstract][Full Text] [Related]
17. Anti-Pseudomonas aeruginosa activity of 1,10-phenanthroline-based drugs against both planktonic- and biofilm-growing cells.
Viganor L; Galdino AC; Nunes AP; Santos KR; Branquinha MH; Devereux M; Kellett A; McCann M; Santos AL
J Antimicrob Chemother; 2016 Jan; 71(1):128-34. PubMed ID: 26416778
[TBL] [Abstract][Full Text] [Related]
18. Superior Bactericidal Efficacy of Fucose-Functionalized Silver Nanoparticles against Pseudomonas aeruginosa PAO1 and Prevention of Its Colonization on Urinary Catheters.
Bhargava A; Pareek V; Roy Choudhury S; Panwar J; Karmakar S
ACS Appl Mater Interfaces; 2018 Sep; 10(35):29325-29337. PubMed ID: 30096228
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of titanium oxide nanoparticles using Aloe barbadensis mill and evaluation of its antibiofilm potential against Pseudomonas aeruginosa PAO1.
Rajkumari J; Magdalane CM; Siddhardha B; Madhavan J; Ramalingam G; Al-Dhabi NA; Arasu MV; Ghilan AKM; Duraipandiayan V; Kaviyarasu K
J Photochem Photobiol B; 2019 Dec; 201():111667. PubMed ID: 31683167
[TBL] [Abstract][Full Text] [Related]
20. Evolution of biofilm-forming pathogenic bacteria in the presence of nanoparticles and antibiotic: adaptation phenomena and cross-resistance.
Mann R; Holmes A; McNeilly O; Cavaliere R; Sotiriou GA; Rice SA; Gunawan C
J Nanobiotechnology; 2021 Sep; 19(1):291. PubMed ID: 34579731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
